NTLA insider trading — Intellia Therapeutics, Inc.
Over the last 90 days, insiders at Intellia Therapeutics, Inc. (NTLA) made 0 open-market purchases worth $0 and 2 open-market sales worth $114K, making them net sellers by $114K. The largest sale was by Dulac Edward J Iii (EVP, Chief Financial Officer), who sold 8,111 shares for $91K on Jul 22, 2026.
Updated Oct 16, 2026.
Recent NTLA insider transactions
Every Form 4 filed by Intellia Therapeutics, Inc. officers, directors and 10% owners in the last 90 days, newest first. P = open-market purchase, S = open-market sale; other codes are awards, option exercises, tax withholding or gifts.
| Trade date | Insider | Role | Type | Ownership | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| Oct 2, 2026 | Dube Michael P | VP, Chief Accounting Officer | S · Sale | Direct | 1,864 | $12.43 | $23K | Form 4 |
| Aug 21, 2026 | Leonard John M | President and CEO | S · Sale · 10b5-1 | Direct | 2,785 | $13.00 | $36K | Form 4 |
| Aug 20, 2026 | Leonard John M | President and CEO | S · Sale · 10b5-1 | Direct | 19,890 | $12.60 | $251K | Form 4 |
| Jul 22, 2026 | Dulac Edward J Iii | EVP, Chief Financial Officer | S · Sale | Direct | 8,111 | $11.25 | $91K | Form 4 |
NTLA insider trading FAQ
Are insiders buying NTLA stock?
Not on the open market. In the last 90 days, Intellia Therapeutics, Inc. insiders made no open-market purchases, and 2 open-market sales totaling $114K. Purchases with the insider's own money are generally seen as a stronger signal than sales, which happen for many reasons (taxes, diversification, planned 10b5-1 sales).
Who are the insiders trading NTLA?
Recent sellers: Dube Michael P, Dulac Edward J Iii.
Where does NTLA insider trading data come from?
Every transaction comes from SEC Form 4 filings on EDGAR. Company officers, directors and 10% owners must file a Form 4 within two business days of buying or selling. InsiderBolt reads these filings directly from the SEC.
More stocks with insider activity
Insider trading data is for informational purposes only and is not investment advice. Filings can be amended; always confirm details on SEC EDGAR.